BDBM50075608 (E)-(S)-4-((2R,5S)-2-Benzyl-5-benzylsulfanylcarbonylamino-6-methyl-4-oxo-heptanoylamino)-6-carbamoyl-hex-2-enoic acid ethyl ester::CHEMBL279889
SMILES: CCOC(=O)\C=C\[C@H](CCC(N)=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)SCc1ccccc1)C(C)C)Cc1ccccc1
InChI Key: InChIKey=OHSCMFHCLMFTFB-BPUKTADQSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human rhinovirus A protease (Human rhinovirus B) | BDBM50075608 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-benzylsulfanylcarbon...) | MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair |